Home > Annual Financials > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS Financial Statement Analysis
[BOM: 539730]

The Revenues of FREDUN PHARMACEUTICALS have increased by 40.03% YoY .
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 42.61 % YoY.
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539730]

ConsolidatedMar2026
Mar2025
Revenues ₹635 Cr₹454 Cr
Expenses ₹545 Cr₹401 Cr
Operating Profit (Excl OI) ₹91 Cr₹52 Cr
Other Income ₹3.66 Cr₹2.45 Cr
Interest ₹39 Cr₹22 Cr
Depreciation ₹8.25 Cr₹5.04 Cr
Profit Before Tax ₹47 Cr₹27 Cr
Profit After Tax ₹33 Cr₹20 Cr
Consolidated Net Profit ₹33 Cr₹20 Cr
Earnings Per Share (Rs)₹59.61₹41.80
PAT Margin (%)5.134.35
ROE(%)16.0913.96
ROCE(%)21.3416.16
Total Debt/Equity(x)0.841.18

Key Financials

Market Cap : ₹ 2,613.0 Cr
Revenue (TTM) : ₹ 869.9 Cr
Net Profit(TTM) : ₹ 53.0 Cr
EPS (TTM) : ₹ 31.0
P/E (TTM) : 49.3

Industry Peers & Returns1W1M1Y
FREDUN PHARMACEUTICALS 3.7% 3.4% 189%
SUN PHARMACEUTICAL INDUSTRIES 1.4% 6.7% 12%
DIVIS LABORATORIES 11.1% 23.5% 70%
TORRENT PHARMACEUTICALS 1% 1.8% 34.3%
CIPLA 0.1% 6% -5.8%
DR REDDYS LABORATORIES 1.1% 11.8% 14.2%
MANKIND PHARMA 3.7% 11.2% 17.4%
LUPIN 1.2% 2.8% 2.5%
ZYDUS LIFESCIENCES -0.5% 4.5% 29.6%


FREDUN PHARMACEUTICALS Revenues
[BOM: 539730]

Y-o-Y

40.03 %

5 Yr CAGR

40.03 %

Years Revenues % Change
Mar2026 ₹635 Cr
40.03
Mar2025 ₹454 Cr -


FREDUN PHARMACEUTICALS Operating Profit
[BOM: 539730]

Y-o-Y

73.29 %

5 Yr CAGR

73.29 %

Years Operating Profit % Change
Mar2026 ₹91 Cr
73.29
Mar2025 ₹52 Cr -

Operating Margins
Y-o-Y

23.79 %

5 Yr CAGR

23.79 %

Years Operating Margin% % Change
Mar2026 14.31%
23.79
Mar2025 11.56% -

FREDUN PHARMACEUTICALS Profit After Tax
[BOM: 539730]

Y-o-Y

65.28 %

5 Yr CAGR

65.28 %

Years Profit After Tax % Change
Mar2026 ₹33 Cr
65.28
Mar2025 ₹20 Cr -

PAT Margins
Y-o-Y

17.93 %

5 Yr CAGR

17.93 %

Years PAT Margin(%) % Change
Mar2026 5.13 %
17.93
Mar2025 4.35 % -

FREDUN PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539730]

Y-o-Y

42.61 %

5 Yr CAGR

42.61 %

Years EPS % Change
Mar2026 ₹60
42.61
Mar2025 ₹42 -

FREDUN PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539730]

Y-o-Y

32.05 %

5 Yr CAGR

32.05 %

Years ROCE % Change
Mar2026 21.34%
32.05
Mar2025 16.16% -

FREDUN PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹1,528.1
Current MarketCap: ₹ 2,613.0 Cr
Updated EOD on :Nov 12,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

3.7%

3.4%

189%

SENSEX

3.3%

13.9%

-1.7%

FREDUN PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 3.1% 8.5% 19.1%
No NSE index found

You may also like the below Video Courses


FAQ about FREDUN PHARMACEUTICALS Financials


How the annual revenues of FREDUN PHARMACEUTICALS have changed ?

The Revenues of FREDUN PHARMACEUTICALS have increased by 40.03% YoY .

How the Earnings per Share (EPS) of FREDUN PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 42.61 % YoY .